Zydus Corporate Park near Vaishnodevi Circle in Chharodi
Ahmedabad: Zydus Lifesciences Ltd reported a 27% year-on-year decline in consolidated net profit to Rs 925.5 crore for the second quarter of FY27, despite a 29% rise in revenue to Rs 7,909.6 crore.The company’s EBITDA fell 6% to Rs 1,894.5 crore during the quarter. EBITDA margin stood at 24%, compared with the previous year’s level. Zydus invested Rs 657.3 crore in research and development during Q2, equivalent to 8.3% of revenue. Organic capital expenditure stood at Rs 465.5 crore. For the first half of FY27, revenue rose 25% year on year to Rs 15,926.6 crore. Net profit declined 31% to Rs 1,885.9 crore. H1 EBITDA fell 7% to Rs 3,823.9 crore, with margins at 24%. The company invested Rs 1,299.7 crore in R&D, accounting for 8.2% of revenue. Organic capital expenditure during the six months stood at Rs 1,053 crore. As of Sept 30, 2026, Zydus reported a net debt-to-equity ratio of 0.19 times. Its net debt-to-EBITDA ratio stood at 0.62 times.
Managing director Sharvil Patel attributed the quarter’s performance to growth across the company’s branded businesses in India, international markets and wellness segments. You Can Also Check: Gold Rate in Ahmedabad | Silver Rate in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad | Ahmedabad AQI | Weather in Ahmedabad | Petrol Price in Ahmedabad | Diesel Price in Ahmedabad | CNG Price in Ahmedabad | LPG Price in Ahmedabad